Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Cure Vac N.V. Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$91.1 Billion
Q4 2024

A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Cure Vac N.V. stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 246,742 shares of CVAC stock, worth $900,608. This represents 0.0% of its overall portfolio holdings.

Number of Shares

246,742

Previous 283,575 12.99%

Holding current value

$900,608

Previous $833,000 0.96%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$2.49 - $3.41 $91,714 - $125,600	-36,833 Reduced 12.99%	246,742 $841,000
Q3 2024 Nov 14, 2024	BUY	$2.74 - $3.79 $11,801 - $16,323	4,307 Added 1.54%	283,575 $833,000
Q2 2024 Aug 14, 2024	BUY	$2.31 - $4.99 $422,462 - $912,591	182,884 Added 189.75%	279,268 $949,000
Q1 2024 May 15, 2024	SELL	$2.94 - $4.34 $34,062 - $50,283	-11,586 Reduced 10.73%	96,384 $292,000
Q4 2023 Feb 14, 2024	SELL	$3.96 - $6.41 $629,418 - $1.02 Million	-158,944 Reduced 59.55%	107,970 $454,000
Q3 2023 Nov 14, 2023	BUY	$6.5 - $10.77 $1.68 Million - $2.78 Million	258,453 Added 3054.64%	266,914 $1.82 Million
Q2 2023 May 17, 2024	SELL	$6.69 - $12.25 $588,204 - $1.08 Million	-87,923 Reduced 91.22%	8,461 $88,000
Q2 2023 Aug 14, 2023	BUY	$6.69 - $12.25 $11,674 - $21,376	1,745 Added 25.98%	8,461 $88,000
Q4 2022 May 17, 2024	SELL	$5.75 - $8.5 $515,591 - $762,178	-89,668 Reduced 93.03%	6,716 $40,000
Q3 2022 Nov 14, 2022	SELL	$7.48 - $15.24 $783,298 - $1.6 Million	-104,719 Reduced 93.97%	6,716 $53,000
Q1 2022 May 16, 2022	SELL	$14.73 - $35.25 $444,359 - $1.06 Million	-30,167 Reduced 21.3%	111,435 $2.19 Million
Q4 2021 Feb 14, 2022	SELL	$33.72 - $48.22 $9.1 Million - $13 Million	-269,842 Reduced 65.58%	141,602 $5.12 Million
Q3 2021 Nov 15, 2021	SELL	$49.26 - $74.5 $5.56 Million - $8.4 Million	-112,796 Reduced 21.52%	411,444 $22.5 Million
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $8.66 Million - $19.4 Million	152,099 Added 40.87%	524,240 $38.5 Million
Q1 2021 May 17, 2021	BUY	$79.79 - $126.29 $29.7 Million - $47 Million	372,141 New	372,141 $34 Million

Others Institutions Holding CVAC

# of Institutions

Shares Held

12.6M

Call Options Held

68.1K

Put Options Held

55.7K

View Full List

About CureVac N.V.

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $684M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

More about CVAC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Cure Vac N.V. Transaction History